Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Ro and Midi Health are telehealth platforms offering GLP-1 medications for weight management, but they operate under distinct clinical models. Ro partners with licensed physicians for individual assessments; Midi Health uses nurse practitioners and physician supervision. Neither guarantees outcomes, and both require medical qualification before dispensing.

Choosing between telehealth providers involves more than convenience—it requires understanding medication sourcing, provider qualifications, biomarker assessment, and how your individual metabolic profile may influence treatment response. This article examines clinical differences to support an informed conversation with your healthcare team.

How Ro and Midi Health Structure Clinical Oversight

Ro requires a one-on-one video consultation with a licensed physician who reviews your medical history, vital signs, and current medications before approving GLP-1 therapy. Physicians on the Ro platform must evaluate contraindications and assess suitability for weight-loss medication according to FDA-approved labeling standards.

Midi Health uses a team-based model: nurse practitioners conduct initial assessments and follow-ups, with physician oversight and medication approval. This model typically offers faster initial consultations and may provide more frequent monitoring touchpoints. Both platforms require ongoing provider relationships; neither offers GLP-1 therapy without medical evaluation and continued provider engagement.

Medication Sources and Formulation Differences

Ro primarily dispenses branded GLP-1 medications (Ozempic, Wegovy) through partner pharmacies. Midi Health also offers branded options alongside compounded semaglutide. Compounded medications are prepared by licensed 503A compounding pharmacies and cost less than brand-name equivalents, though they lack the same manufacturing oversight as FDA-approved products.

PlexusDx exclusively sources compounded GLP-1 medications from 503A licensed compounding pharmacies, offering semaglutide and tirzepatide at lower price points ($149/mo) compared to branded alternatives. Compounded formulations provide flexibility in dosing but should be obtained only through verified, licensed compounding partners under physician supervision.

Provider Model Medication Access Initial Cost Range Provider Type
Ro Branded GLP-1 (Wegovy, Ozempic) $300–$500+/mo Licensed Physician
Midi Health Branded or Compounded Options $250–$400+/mo Nurse Practitioner + Physician
PlexusDx Compounded Only (503A) $149/mo Licensed Pharmacy + Your Provider
Direct Pharmacy Varies (Compounded or Branded) $150–$350/mo Pharmacist + Your Provider

Biomarker Assessment and Personalized Baseline Evaluation

Neither Ro nor Midi Health routinely orders baseline biomarkers (fasting glucose, insulin levels, lipid panel) before initiating GLP-1 therapy, though physicians may request labs if clinical history warrants. Baseline biomarkers help establish metabolic context and can guide dosing decisions, particularly in patients with prediabetes or metabolic syndrome.

A comprehensive pre-treatment assessment—including metabolic markers and genetic predisposition screening—supports more personalized treatment planning. Understanding your baseline insulin sensitivity, HbA1c, and lipid profile gives your provider quantitative data to guide medication choice and monitor response over time, complementing the clinical evaluation telehealth platforms provide.

Who Should Qualify and Safety Considerations Across Platforms

GLP-1 medications are indicated for patients with BMI ≥27 with weight-related comorbidities (hypertension, type 2 diabetes, dyslipidemia) or BMI ≥30 regardless of comorbidity status. Contraindications include personal/family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or pregnancy. All telehealth providers screen for these during physician or nurse practitioner consultation.

Side effects—nausea, constipation, pancreatitis risk—require provider monitoring regardless of platform. Patients should expect regular check-ins, dose adjustments based on tolerance, and screening for gastrointestinal complications. Those with a history of gastroparesis, pancreatitis, or severe renal impairment may not qualify. Your provider's accessibility and follow-up frequency matter as much as medication cost when evaluating any telehealth option.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines predispositions in key GLP-1 pathway variants (GIPR rs1800437, GLP1R rs6923761, MC4R rs17782313, FTO rs9939609) that may help provide context for how your body responds to GLP-1 medications. These genetic markers reflect metabolic susceptibility, not a guarantee of medication efficacy. Results should be interpreted with your qualified healthcare provider as one input among medical history, biomarkers, and clinical assessment.

The genetic test ($99 add-on or $298 standalone) reveals whether you carry variants associated with greater GLP-1 sensitivity or metabolic predisposition toward weight gain—information that can support conversations with your provider about dosing strategy, medication choice (semaglutide vs. tirzepatide), or combination protocols like PlexusDx's GLP-Squared dual compound ($249/mo).

When evaluating Ro, Midi Health, or other telehealth providers, genetic insights can help you ask informed questions about personalization. Combined with biomarker assessment and your clinical history, genetic predisposition data supports a more targeted conversation about whether compounded or branded GLP-1 therapy best aligns with your metabolic profile and treatment goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which platform offers faster approval—Ro or Midi Health?

Midi Health's nurse practitioner model typically approves patients within 24–48 hours; Ro's physician consultations may take 1–3 days. Speed varies by demand. Both require thorough medical evaluation before dispensing GLP-1 medication.

Can I switch from Ro to Midi Health mid-treatment?

Yes. Switching platforms requires your new provider to review your GLP-1 treatment history, current dose, tolerance, and goals. Medical records transfer between providers; medication sourcing may change (branded vs. compounded), so discuss cost and formulation implications with your new provider.

How does PlexusDx pricing compare to Ro and Midi Health?

PlexusDx compounded semaglutide costs $149/mo; tirzepatide, $249/mo. Ro and Midi Health typically charge $300–$500/month for branded medications. Compounded formulations from licensed 503A pharmacies offer lower cost but lack FDA approval status.

What if I have prediabetes—does that change which provider to choose?

Prediabetes may qualify you for GLP-1 therapy if BMI ≥27 with comorbidities. All reputable telehealth providers screen for this. Ask whether your provider orders baseline glucose and HbA1c; some do, others request labs separately. Biomarker context strengthens treatment monitoring.

How can genetic testing help me decide between telehealth options?

PlexusDx's Precision Peptide Genetic Test shows GLP-1 pathway predispositions (GIPR, GLP1R, MC4R variants) that may inform dosing or medication choice. Results don't predict exact response but can guide provider conversations about personalized protocols, including compounded combinations like GLP-Squared.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves